Literature DB >> 3143150

Up-regulation of the expression of secretory component and HLA molecules in a human colonic cell line by tumour necrosis factor-alpha and gamma interferon.

D Kvale1, P Brandtzaeg, D Løvhaug.   

Abstract

Secretory component (SC) acts as a receptor for polymeric IgA (pIgA) and pIgM on the basolateral face of secretory epithelia. This study showed that both the production and surface membrane expression of SC were additively up-regulated by tumour necrosis factor-alpha (TNF) and gamma interferon (IFN-gamma) in a human colonic cell line (HT-29m2). TNF likewise enhanced membrane expression of HLA class I determinants. Moreover, TNF augmented synergistically the IFN-induced de novo synthesis of HLA class II (DR) molecules. These data suggest that there are different regulatory mechanisms for the action of TNF and IFN and for the expression of HLA-DR and SC/HLA class I. Addition of actinomycin D abolished the cytokine-mediated increase of SC synthesis and expression. This observation suggested that transcriptional events are required for the cytokine-mediated up-regulation of SC.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143150     DOI: 10.1111/j.1365-3083.1988.tb01460.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  26 in total

1.  Calorie restriction decreases proinflammatory cytokines and polymeric Ig receptor expression in the submandibular glands of autoimmune prone (NZB x NZW)F1 mice.

Authors:  A R Muthukumar; C A Jolly; K Zaman; G Fernandes
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

2.  Characterisation and quantification of mucosal cytokine that induces epithelial histocompatibility locus antigen-DR expression in inflammatory bowel disease.

Authors:  J R Lowes; P Radwan; J D Priddle; D P Jewell
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

3.  Role of local cytokines in increased gastric expression of the secretory component in Helicobacter pylori infection.

Authors:  I Ahlstedt; C Lindholm; H Lönroth; A Hamlet; A M Svennerholm; M Quiding-Järbrink
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Relation between T cell number and epithelial HLA class II expression quantified by image analysis in normal and inflamed human gastric mucosa.

Authors:  K Valnes; H S Huitfeldt; P Brandtzaeg
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

5.  Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance.

Authors:  M Kjerrulf; D Grdic; L Ekman; K Schön; M Vajdy; N Y Lycke
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

6.  Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor.

Authors:  T Ferkol; C S Kaetzel; P B Davis
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

7.  Phenotypic and functional characterization of T-cell lines generated from colonoscopic biopsy specimens in patients with ulcerative colitis.

Authors:  K Kusugami; J Haruta; M Ieda; M Shinoda; T Ando; A Kuroiwa; K Ina; H Iokawa; A Ishihara; S Sarai
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

8.  Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells.

Authors:  J Rugtveit; G Haraldsen; A K Høgåsen; A Bakka; P Brandtzaeg; H Scott
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

9.  Secretory immunoglobulins in serum from human immunodeficiency virus (HIV)-infected patients.

Authors:  C Vincent; G Cozon; M Zittoun; M Mellquist; M D Kazatchkine; C Czerkinsky; J P Revillard
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

10.  Surface expression of secretory component and HLA class II DR antigen on glandular epithelial cells from human endometrium and two endometrial adenocarcinoma cell lines.

Authors:  A C Menge; J Mestecky
Journal:  J Clin Immunol       Date:  1993-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.